You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SABS Disposition Disclosure
Kropotova Alexandra · SEC Form 4 · Filed Sep 18, 2026
Disposition
Reported value range
Not reported
Kropotova Alexandra Chief Medical Officer
SABS
SAB Biotherapeutics
SABS
Transaction date
Sep 17, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 1 day later
SABS daily price context
Close on/before transaction
$3.5
Sep 17, 2026
First close after public filing
$3.39
Sep 21, 2026
30-day return after filing
-23.3%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 473 shares
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001193125-26-395552
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sab Biotherapeutics, Inc. SABS Current | Disposition | Sep 17, 2026 | Not reported |